Cargando…

Independent Clinical Factors Relevant to Prognosis of Patients with Idiopathic Pulmonary Fibrosis

BACKGROUND: The prognosis of idiopathic pulmonary fibrosis (IPF) is the worst among all interstitial lung diseases, and is related to the disease itself. Comorbidities or complications can worsen IPF. We assessed the effect of comorbidities on the survival of IPF patients. A retrospective review of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Huifang, Sun, Dejun, Ban, Chengjun, Liu, Yan, Zhu, Min, Ye, Qiao, Yan, Wei, Ren, Yanhong, Dai, Huaping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2019
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6563649/ https://www.ncbi.nlm.nih.gov/pubmed/31166938 http://dx.doi.org/10.12659/MSM.914725

Ejemplares similares

Small airway dysfunction in Chinese patients with idiopathic pulmonary fibrosis
por: Zhang, Xinran, et al.
Publicado: (2022)

Idiopathic Pulmonary Fibrosis Registry China study (PORTRAY): protocol for a prospective, multicentre registry study
por: Xie, Bingbing, et al.
Publicado: (2020)

Blood monocyte counts as a prognostic biomarker and predictor in Chinese patients with idiopathic pulmonary fibrosis
por: Zhang, Xinran, et al.
Publicado: (2022)

Krebs von den Lungen‐6 levels in untreated idiopathic pulmonary fibrosis
por: Jiang, Dingyuan, et al.
Publicado: (2022)

Direct medical costs of hospitalized patients with idiopathic pulmonary fibrosis in a tertiary hospital in China
por: Zheng, Xiao-Fen, et al.
Publicado: (2020)

External validation of the GAP model in Chinese patients with idiopathic pulmonary fibrosis
por: Zhang, Xinran, et al.
Publicado: (2022)

Fatty Acid Metabolism and Idiopathic Pulmonary Fibrosis
por: Geng, Jing, et al.
Publicado: (2022)

Idiopathic Pulmonary Fibrosis: Treatment and Prognosis
por: Fujimoto, Hajime, et al.
Publicado: (2016)

Therapeutic Applications of Mesenchymal Stem Cells in Idiopathic Pulmonary Fibrosis
por: Yang, Shengnan, et al.
Publicado: (2021)

Incidence and Clinical Characteristics of Pulmonary Hypertension in Patients with Idiopathic Pulmonary Fibrosis
por: Yan, Wei, et al.
Publicado: (2015)

Feasibility and Mechanism Analysis of Shenfu Injection in the Treatment of Idiopathic Pulmonary Fibrosis
por: Liu, Peipei, et al.
Publicado: (2021)

Prognosis and Follow-Up of Idiopathic Pulmonary Fibrosis
por: Fernández Fabrellas, Estrella, et al.
Publicado: (2018)

Elastic Registration Algorithm Based on Three-dimensional Pulmonary MRI in Quantitative Assessment of Severity of Idiopathic Pulmonary Fibrosis
por: Yang, Xiaoyan, et al.
Publicado: (2023)

Prognosis of combined pulmonary fibrosis and emphysema: comparison with idiopathic pulmonary fibrosis alone
por: Jiang, Chun-guo, et al.
Publicado: (2019)

Patient Registries in Idiopathic Pulmonary Fibrosis
por: Culver, Daniel A., et al.
Publicado: (2019)

Meta-Analysis of Genetic Programs between Idiopathic Pulmonary Fibrosis and Sarcoidosis
por: Leng, Dong, et al.
Publicado: (2013)

Genetics in Idiopathic Pulmonary Fibrosis Pathogenesis, Prognosis, and Treatment
por: Kaur, Amarpreet, et al.
Publicado: (2017)

Editorial: Idiopathic pulmonary fibrosis: epidemiology, prognosis and treatment
por: Caminati, Antonella, et al.
Publicado: (2023)

Alterations to the Lung Microbiome in Idiopathic Pulmonary Fibrosis Patients
por: Tong, Xunliang, et al.
Publicado: (2019)

Effect and Safety of Mycophenolate Mofetil in Idiopathic Pulmonary Fibrosis
por: Tzouvelekis, Argyris, et al.
Publicado: (2011)

Soluble ST2 in serum predicts the prognosis of idiopathic pulmonary fibrosis: a retrospective study
por: Yu, Yan-Zhe, et al.
Publicado: (2022)

Idiopathic pulmonary fibrosis associated with circulating autoantibodies: a Chinese cohort of a long-term follow-up study
por: Wang, Hui, et al.
Publicado: (2022)

The potential role of interleukin (IL)‐25/IL‐33/thymic stromal lymphopoietin (TSLP) on the pathogenesis of idiopathic pulmonary fibrosis
por: Xu, Xuefeng, et al.
Publicado: (2022)

Clinical characteristics and prognosis of idiopathic pulmonary hemosiderosis in pediatric patients
por: Zhang, Yajun, et al.
Publicado: (2018)

Severity classification for idiopathic pulmonary fibrosis by using fuzzy logic
por: Lopes, Agnaldo José, et al.
Publicado: (2011)

Genetic studies provide clues on the pathogenesis of idiopathic pulmonary fibrosis
por: Kropski, Jonathan A., et al.
Publicado: (2013)

Prognosis and longitudinal changes of physical activity in idiopathic pulmonary fibrosis
por: Bahmer, Thomas, et al.
Publicado: (2017)

Establishment and application of the BRP prognosis model for idiopathic pulmonary fibrosis
por: Cheng, Xiaoyun, et al.
Publicado: (2023)

Correlation between serum bilirubin levels and the severity as well as the prognosis of idiopathic pulmonary fibrosis
por: Shi, Shenyun, et al.
Publicado: (2020)

Poorer Prognosis of Idiopathic Pleuroparenchymal Fibroelastosis Compared with Idiopathic Pulmonary Fibrosis in Advanced Stage
por: Shioya, Makoto, et al.
Publicado: (2018)

Relevance of RNA N6-Methyladenosine Regulators for Pulmonary Fibrosis: Implications for Chronic Hypersensitivity Pneumonitis and Idiopathic Pulmonary Fibrosis
por: Zhou, Yiyi, et al.
Publicado: (2022)

Down-regulation of USP13 mediates phenotype transformation of fibroblasts in idiopathic pulmonary fibrosis
por: Geng, Jing, et al.
Publicado: (2015)

Lung shrinking assessment on HRCT with elastic registration technique for monitoring idiopathic pulmonary fibrosis
por: Sun, Haishuang, et al.
Publicado: (2022)

Prognosis of non-small-cell lung cancer in patients with idiopathic pulmonary fibrosis
por: Han, SongYi, et al.
Publicado: (2019)

Prognosis of Small Cell Lung Cancer with Idiopathic Pulmonary Fibrosis: Assessment according to GAP Stage
por: Song, Myung Jin, et al.
Publicado: (2019)

4569 Burden of illness in idiopathic pulmonary fibrosis: A real-world cohort
por: Farrand, Erica, et al.
Publicado: (2020)

A functional genomic model for predicting prognosis in idiopathic pulmonary fibrosis
por: Huang, Yong, et al.
Publicado: (2015)

Impact of mediastinal lymph node enlargement on the prognosis of idiopathic pulmonary fibrosis
por: Sin, Sooim, et al.
Publicado: (2018)

Colitis Associated with Nintedanib Therapy for Idiopathic Pulmonary Fibrosis (IPF)
por: Oda, Keishi, et al.
Publicado: (2017)

Idiopathic pulmonary fibrosis
por: Meltzer, Eric B, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_9sr3ch2qtltsv24ct4p59j7sp6